\BOOKMARK [1][-]{section.1}{Einleitung}{}% 1
\BOOKMARK [1][-]{section.2}{Grundlagen}{}% 2
\BOOKMARK [1][-]{section.3}{Therapieziel Wirkung}{}% 3
\BOOKMARK [1][-]{section.4}{Input Beziehung zur Konzentration}{}% 4
\BOOKMARK [1][-]{section.5}{Elimination, Umverteilung}{}% 5
\BOOKMARK [1][-]{section.6}{Input und Elimination}{}% 6
\BOOKMARK [1][-]{section.7}{Elimination, Halbwertszeit}{}% 7
\BOOKMARK [2][-]{subsection.7.1}{Elimination, Context sensitive Halbwertszeit}{section.7}% 8
\BOOKMARK [1][-]{section.8}{Pharmakodynamik}{}% 9
\BOOKMARK [2][-]{subsection.8.1}{PD und Elimination}{section.8}% 10
\BOOKMARK [2][-]{subsection.8.2}{Elimination, Relevanter Konzentrationsabfall}{section.8}% 11
\BOOKMARK [1][-]{section.9}{Wirkortkonzentration}{}% 12
\BOOKMARK [2][-]{subsection.9.1}{tpeak}{section.9}% 13
\BOOKMARK [1][-]{section.10}{Pharmakokinetische Modelle}{}% 14
\BOOKMARK [1][-]{section.11}{Verwendung der Modelle: TCI}{}% 15
\BOOKMARK [1][-]{section.12}{An\344sthetika \(im engeren Sinne\)}{}% 16
\BOOKMARK [2][-]{subsection.12.1}{i.v. Hypnotika}{section.12}% 17
\BOOKMARK [2][-]{subsection.12.2}{i.v. Opiate}{section.12}% 18
\BOOKMARK [1][-]{section.13}{Praxis der TIVA}{}% 19
\BOOKMARK [2][-]{subsection.13.1}{i.v. An\344sthesie mit TCI}{section.13}% 20
\BOOKMARK [2][-]{subsection.13.2}{i.v. Applikation: TIVA / TCI}{section.13}% 21
\BOOKMARK [1][-]{section.14}{Repetition}{}% 22
